Literature DB >> 3749421

Mixed organic brain syndrome as a manifestation of systemic mastocytosis.

M P Rogers, K Bloomingdale, B J Murawski, N A Soter, P Reich, K F Austen.   

Abstract

Systemic mastocytosis is a disease characterized by an excessive accumulation of mast cells, and associated with skin lesions, flushing, diarrhea, tachycardia, and psychiatric manifestations. In order to define more clearly the psychiatric manifestations, ten patients with this disorder underwent unstructured psychiatric interviews and a battery of psychologic testing. Both revealed a pattern of cognitive and affective changes in the majority of these patients, best categorized as an atypical or mixed organic brain syndrome. The cognitive changes consisted of diminished attention and memory, and the affective changes of anger, irritability, and, to a lesser extent, depression. These manifestations fluctuated with the level of disease activity, and appeared in some cases to respond to histamine antagonists and disodium cromoglycate, medications used to control the excessive mast cell activity. It is important for psychiatrists to be aware that mental status changes can represent psychiatric manifestations of mastocytosis, a readily treatable medical disorder.

Entities:  

Mesh:

Year:  1986        PMID: 3749421     DOI: 10.1097/00006842-198607000-00006

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  12 in total

Review 1.  Interactions of mast cells with the nervous system--recent advances.

Authors:  D Johnson; W Krenger
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

2.  Mastocytosis and Sjögren's syndrome.

Authors:  D J Bac; M van Marwijk Kooy
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

3.  Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.

Authors:  S Georgin-Lavialle; D S Moura; A Salvador; J-C Chauvet-Gelinier; J-M Launay; G Damaj; F Côté; E Soucié; M-O Chandesris; S Barète; C Grandpeix-Guyodo; C Bachmeyer; M-A Alyanakian; A Aouba; O Lortholary; P Dubreuil; J-R Teyssier; B Trojak; E Haffen; P Vandel; B Bonin; O Hermine; R Gaillard
Journal:  Mol Psychiatry       Date:  2016-01-26       Impact factor: 15.992

4.  Regulation of normal and neoplastic human mast cell development in mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

5.  Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.

Authors:  Daniela Silva Moura; Serge Sultan; Sophie Georgin-Lavialle; Nathalie Pillet; François Montestruc; Paul Gineste; Stéphane Barete; Gandhi Damaj; Alain Moussy; Olivier Lortholary; Olivier Hermine
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

6.  Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression.

Authors:  Daniela Silva Moura; Serge Sultan; Sophie Georgin-Lavialle; Stéphane Barete; Olivier Lortholary; Raphael Gaillard; Olivier Hermine
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

Review 7.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14

Review 8.  An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.

Authors:  Stephen D Skaper; Laura Facci; Morena Zusso; Pietro Giusti
Journal:  Front Cell Neurosci       Date:  2018-03-21       Impact factor: 5.505

9.  Neuroimaging evidence of brain abnormalities in mastocytosis.

Authors:  N Boddaert; A Salvador; M O Chandesris; H Lemaître; D Grévent; C Gauthier; O Naggara; S Georgin-Lavialle; D S Moura; F Munsch; N Jaafari; M Zilbovicius; O Lortholary; R Gaillard; O Hermine
Journal:  Transl Psychiatry       Date:  2017-08-08       Impact factor: 6.222

10.  Case-control cohort study of patients' perceptions of disability in mastocytosis.

Authors:  Olivier Hermine; Olivier Lortholary; Phillip S Leventhal; Adeline Catteau; Frédérique Soppelsa; Cedric Baude; Annick Cohen-Akenine; Fabienne Palmérini; Katia Hanssens; Ying Yang; Hagay Sobol; Sylvie Fraytag; David Ghez; Felipe Suarez; Stéphane Barete; Philippe Casassus; Beatrice Sans; Michel Arock; Jean Pierre Kinet; Patrice Dubreuil; Alain Moussy
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.